In situ human papillomavirus (HPV) genotyping of cervical intraepithelial neoplasia in South African and British patients: evidence for putative HPV integration in vivo

Keyphrases

• In Situ 100%
• South African 100%
• Patient Evidence 100%
• Cervical Intraepithelial Neoplasia 100%
• Human Papillomavirus Genotypes 100%
• Human Papillomavirus Integration 100%
• Biopsy Specimen 50%
• South Africa 50%
• Human Papillomavirus Types 50%
• In Situ Hybridization 33%
• Virus Infection 33%
• High-risk Human Papillomavirus (HR-HPV) 33%
• Punctate 33%
• Warts 33%
• South African Women 33%
• United Kingdom 16%
• Age-matched 16%
• Undifferentiated Cells 16%
• Ethnic Groups 16%
• Infection Rate 16%
• Combined Type 16%
• British Woman 16%
• HPV16 16%
• Human Papillomavirus 6 16%
• Human Papillomavirus 33 16%
• Superficial Cells 16%
• Human Papillomavirus Testing 16%
• Koilocytes 16%
• Digoxigenin-labeled Probe 16%
• Signal Type 16%
• Black Women 16%
• Morphological Criteria 16%
• Diffuse Type 16%

Medicine and Dentistry

• Wart Virus 100%
• Cervical Intraepithelial Neoplasia 100%
• Biopsy Technique 27%
• Virus Infection 18%
• In Situ Hybridization 18%
• Morphology 9%
• Prevalence 9%
• Ethnic Group 9%
• Human Papillomavirus Type 16 9%
• Human Papillomavirus Type 11 9%
• Human Papillomavirus Type 6 9%
• Human Papillomavirus Type 33 9%
• Digoxigenin 9%
• Human Papillomavirus Type 35 9%

Immunology and Microbiology

• Wart Virus 100%
• Viral Disease 18%
• In Situ Hybridization 18%
• Morphology 9%
• Prevalence 9%
• Human Papillomavirus Type 16 9%
• Human Papillomavirus Type 11 9%
• Human Papillomavirus Type 6 9%
• Human Papillomavirus Type 33 9%
• Human Papillomavirus Type 35 9%